AdhexPharma

Chenove, France Founded: 2008 • Age: 18 yrs
Developer of trans-dermal, topical delivery systems, and oral thin films

About AdhexPharma

AdhexPharma is a Healthcare company based in Chenove (France) founded in 2008. Developer of trans-dermal, topical delivery systems, and oral thin films. AdhexPharma has completed 1 acquisition, including tesa Labtec. Its website adhexpharma.com draws about 10 thousand monthly visits. AdhexPharma offers products and services including Oral Films, Mucofilm®, Rapidfilm®, Impregnated Matrix Patch, and Transfilm®. Its focus areas include Diversified Pharmaceuticals, Life Sciences, Drug Delivery and Diversified.

Company details

AdhexPharma is a French pharmaceutical company specialized in transdermal and topical delivery systems (TDS) and oral thin films (OTF). The company offers its formulation and drug delivery services and CMO services to its clients.

  • Headquarters Chenove, France
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website adhexpharma.com
  • Social LinkedIn X
Key Metrics

Products & Services of AdhexPharma

AdhexPharma offers a comprehensive portfolio of products and services, including Oral Films, Mucofilm®, Rapidfilm®, Impregnated Matrix Patch, and Transfilm®.

Oral Films
Drug Delivery

Fast dissolving films for oral administration of medications

Mucofilm®
Oral Films

Specialized oral film for rapid drug dissolution and delivery

Rapidfilm®
Oral Films

Oral film technology for efficient API absorption

Impregnated Matrix Patch
Drug Delivery

Patch system for topical or transdermal drug application

Transfilm®
Drug Delivery

Transdermal patch for controlled medication release

Funding Insights of AdhexPharma

  • Total Rounds 2
  • Last Round Grant — $765,269
  • First Round $574,444

    (Oct 2019)

  • Investors Count 1

All 2 funding rounds of AdhexPharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2023$765,269Grant––
Oct 2019$574,444Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in AdhexPharma

AdhexPharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for AdhexPharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of AdhexPharma

14 people are tracked at AdhexPharma (4 in leadership, 10 in team).

NameRoleGroup
Nils Hesselink
Head Of FinanceLeadership
Marion Tegelkamp
Head Of Analytics And Quality ControlLeadership
Dr. Dominic Docter
Head Of Quality Management And Quality AssuranceLeadership
Ralf Kibele
Managing Director of Labtec GmbHLeadership
Christine Kaufmann
Marketing Communication ManagerinTeam
Hanna Ponsar
Project & Laboratory Manager Formulation DevelopmentTeam
Dr. Christian Müller
Team Leader Quality ControlTeam
Katja Göbel
Lab TechnicianTeam
Karin Dallaway
Quality ManagerTeam
Annika Mutz
Laboratory TechnicianTeam
Dr. Svenja Niese
Lab Manager AnalyticsTeam
Emrah Yıldır
Business Development ManagerTeam
Stefanie Giesler
Assistant HR And Marketing & Sales Tesa Labtec GmbhTeam
Antje Below
Project And Customer ManagementTeam
Premium access

Complete people profiles for AdhexPharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AdhexPharma

AdhexPharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include tesa Labtec.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Oral film and transdermal drug delivery
tesa-labtec.comLangenfeld, Germany2013Sep 2022••••
Premium access

Complete acquisition details for AdhexPharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of AdhexPharma

4 dated milestones of AdhexPharma across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded AdhexPharma is founded.
  2. Funding First funding round of $574K.
  3. Acquisition Acquires tesa Labtec.
  4. Funding Latest funding round, Grant, of $765K.

Web traffic of AdhexPharma

The website of AdhexPharma (adhexpharma.com) receives about 10.1K visits a month.

  • Monthly visits
    10.1K

    ▼ 12.8% vs previous month

Similar websites

Websites whose visitors overlap most with AdhexPharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nicotex.in
100%
30.2KView details
green-exchange.eu
green-exchange.eu
96%
#10,760,592–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Adhexpharma

Adhex Pharma’s Acquisition of tesa Labtec GmbH
Globallegalchronicle • 4 years ago
Premium access

Complete news archive for AdhexPharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AdhexPharma

AdhexPharma was founded in 2008 and raised its 1st funding round 11 years after it was founded.

AdhexPharma is headquartered in Chenove, France.

AdhexPharma is a French pharmaceutical company specialized in transdermal and topical delivery systems (TDS) and oral thin films (OTF). The company offers its formulation and drug delivery services and CMO services to its clients.

AdhexPharma offers Oral Films, Mucofilm®, Rapidfilm®, Impregnated Matrix Patch, and Transfilm®.

AdhexPharma has made 1 acquisition, including tesa Labtec.

AdhexPharma has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available